COVID Olfactory Trial Hints at Possible Benefit

Small sample size limits significance of findings

One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study, BMC Medicine

IJMS, Free Full-Text

These doctors are treating COVID-19 smell loss by sticking plasma-soaked sponges up people's noses

Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers - eClinicalMedicine

New Findings Help Make Sense of Brain Fog From Long COVID

Olfactory training for olfactory dysfunction in COVID‐19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic - Ojha - 2022 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Considerations for diagnostic COVID-19 tests

Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments

Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6

COVID Smell Loss: 'Retraining' Mostly Flops in Trial

Frontiers COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial - eClinicalMedicine